News

Manufacturers of neurotechnology systems often look to a network of suppliers of components and engineering services to get their products to market faster and more economically. These supplier firms offer critical components such as batteries, housings, leads, and interconnects. Recently, several firms in this area made announcements or joined forces in an effort to attract more customers from the neurotech industry.

Much of the progress in bioelectronic medicine to date has been driven , whether the mode of stimulation was electrical, optical, ultrasound, or some other medium. But sensing and diagnostic technology is also important, in part to exploit new closed loop neuromodulation technologies, but also help determine the optimal therapeutic intervention, including pharmaceutical, device, or biologics approaches.

As 2026 begins, the neuromodulation industry has never been more exciting with a significant number of startup companies, applications, and innovations attracting investor interest. However, one sector continues to drag on the investment and valuation side, specifically spinal cord stimulation, a market more than six decades in the making that has reached a level of maturity where sustaining growth and defending valuations has become increasingly difficult.

The market for brain-computer interfaces continues to attract new entrants and new technologies, fueled in large part venture capital investment in the space. The latest U.S. entrant in this market is a spinoff from Columbia University called Kampto Neurotech. The company plans to commercialize a flexible, subdural brain implant with 65,000 electrodes and 1,024 channels. Fabricated as a single chip…

The month of January is generally a busy month for the neurotechnology industry and 2026 was no exception. Neurotech Reports’ editors participated in a number of events during and collected enough news and background information for a whole year’s worth of coverage, or so it seemed. The year began with a trip to Las Vegas for the CES show, where this editor and senior consulting editor Jeremy Koff surveyed numerous new product offerings in wearable and noninvasive technologies.

Transcutaneous electrical stimulation devices can be subdivided into three major categories: TENS, tVNS, and cranial electrotherapy stimulators, based on electrode placement on the body. TENS devices are used below the neck, tVNS devices are applied at the neck or ear, and CES devices are used above the neck. Although these devices are functionally similar, their FDA classifications differ significantly.

In a rare scheduling shift, the IEEE Engineering Medicine and Biology society shifted its biannual Neural Engineering (NER) conference from spring to late fall last month in San Diego. Sandwiched between the Neurotech Leaders Forum in San Francisco and buttressed immediately against Society for Neuroscience, the conference provided a meaningful bridge between the industry and commercialization focus of the former and the heavily pre-clinical and early research concentration of the latter.

As was the case in 2024, the year 2025 continued the progression of good news for the neurotechnology industry. And as was the case last year, this year was marked . While Boston Scientific’s $600 million purchase of Nalu was less than that firm’s $3.7 billion deal with Axonics in 2024, it pointed out the potential for startup PNS firms. As Jeremy Koff points out in his article on page 6 of this is…

For more than half a century, active implantable medical devices have been constrained energy into the body safely and efficiently. Whether used to power a device directly or recharge a deeply implanted battery, energy transfer physics have limited implant placement, longevity, size, and patient convenience. While electronics, sensing, materials, and algorithms have advanced rapidly, energy transfer from outside the body to within remains one of the defining limitations of implant design.

At the recent Society for Neuroscience meeting in San Diego, CA earlier this month, a panel of BCI researchers and clinicians participated in a press conference devoted to restoring touch, speech, and movement to paralyzed individuals. The press conference was moderated , director of the Neuro-X Institute at EPFL and founder of ONWARD Medical. Other panelists included Robert Gaunt, associate profes…